Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Recommendation of “Hold” from Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has been assigned an average recommendation of “Hold” from the seventeen analysts that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and five have assigned a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $7.6667.

Several equities research analysts have recently weighed in on the company. Weiss Ratings upgraded Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, May 22nd. Barclays dropped their price objective on Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a report on Thursday, March 26th. Citigroup increased their target price on Teladoc Health from $6.00 to $7.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 5th. Finally, Bank of America lifted their target price on Teladoc Health from $9.00 to $10.50 and gave the stock a “buy” rating in a research report on Tuesday, July 7th.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 7,906 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $60,322.78. Following the completion of the sale, the insider directly owned 110,261 shares of the company’s stock, valued at $841,291.43. The trade was a 6.69% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Carlos Nueno sold 6,196 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $47,275.48. Following the completion of the transaction, the insider owned 57,671 shares in the company, valued at $440,029.73. This represents a 9.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 39,195 shares of company stock valued at $299,058. Company insiders own 0.70% of the company’s stock.

Institutional Trading of Teladoc Health

Several institutional investors and hedge funds have recently modified their holdings of the stock. IFP Advisors Inc grew its stake in Teladoc Health by 412.1% in the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after purchasing an additional 3,210 shares in the last quarter. PNC Financial Services Group Inc. raised its position in Teladoc Health by 177.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 2,810 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in Teladoc Health by 694.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 4,945 shares in the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Teladoc Health in the 4th quarter worth $45,000. Finally, Versant Capital Management Inc lifted its holdings in shares of Teladoc Health by 33.3% in the 2nd quarter. Versant Capital Management Inc now owns 8,207 shares of the health services provider’s stock worth $70,000 after buying an additional 2,052 shares during the period. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Performance

Shares of NYSE:TDOC opened at $9.27 on Monday. The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75. Teladoc Health has a 12 month low of $4.40 and a 12 month high of $9.77. The company has a market capitalization of $1.67 billion, a price-to-earnings ratio of -9.56 and a beta of 2.10. The firm’s 50-day moving average is $7.53 and its 200 day moving average is $6.36.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.01). Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.The firm had revenue of $613.85 million during the quarter, compared to the consensus estimate of $611.04 million. During the same period in the previous year, the business earned ($0.53) EPS. The firm’s revenue for the quarter was down 2.5% on a year-over-year basis. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. Research analysts predict that Teladoc Health will post -0.92 EPS for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.